PakMediNet Discussion Forum : Medicine : Nanotech in Lahore
Wow a advanced clinic in Lahore
Posted by: ikhan700Posts: 15 :: 11-01-2007 :: | Reply to this Message
AoA
It is very good that Nonotech lab in lahore, but plz explain it,
what is the purpose of lab, what type of research will be done, where it is located
i think you should explain all these things
regards
aftab
Posted by: aftabacPosts: 271 :: 12-01-2007 :: | Reply to this Message
Nanotech is located in 56 e-2 Wapda town Lahore.
Treatment is limited to selected patients, we treat all conditions, all systems, specially neuro, psych , rheumatic and carido.
Reasearch is also being done with nanoparticles to preventa and treat all infections incuding aids. Targeting low cost.
We are also useing low frequency electrical stimulation to kill cancer cells.
I.khan
Posted by: ikhan700Posts: 15 :: 27-01-2007 :: | Reply to this Message
Please also check www.cidpusa.org
Posted by: ikhan700Posts: 15 :: 27-01-2007 :: | Reply to this Message
Dear Dr. Khan,
May we ask you to enlighten us with the scientific evidence behind the use of nanoparticles to prevent and treat all infections including AIDS? Also if you can shed light on the scientific evidence supporting low frequency electrical stimulation to kill cancer cells (I assume you are not talking about radiation treatment).
Posted by: rqayyumPosts: 199 :: 29-01-2007 :: | Reply to this Message
1: Tokmakci M. Related Articles, Links
A high-voltage pulse generation instrument for electrochemotherapy method.
J Med Syst. 2006 Jun;30(3):145-51.
PMID: 16848127 [PubMed - indexed for MEDLINE]
2: Haemmerich D, Wood BJ. Related Articles, Links
Hepatic radiofrequency ablation at low frequencies preferentially heats tumour tissue.
Int J Hyperthermia. 2006 Nov;22(7):563-74.
PMID: 17079214 [PubMed - indexed for MEDLINE]
3: Tokmakci M. Related Articles, Links
A high-voltage pulse generation instrument for electrochemotherapy method.
J Med Syst. 2006 Jun;30(3):145-51.
PMID: 16848127 [PubMed - indexed for MEDLINE]
4: Huang L, Dong L, Chen Y, Qi H, Xiao D. Related Articles, Links
Effects of sinusoidal magnetic field observed on cell proliferation, ion concentration, and osmolarity in two human cancer cell lines.
Electromagn Biol Med. 2006;25(2):113-26.
PMID: 16771300 [PubMed - indexed for MEDLINE]
5: : Ekstrand V, Wiksell H, Schultz I, Sandstedt B, Rotstein S, Eriksson A. Related Articles, Links
Influence of electrical and thermal properties on RF ablation of breast cancer: is the tumour preferentially heated?
Biomed Eng Online. 2005 Jul 11;4:41.
PMID: 16008834 [PubMed - indexed for MEDLINE]
6: Kurokawa Y, Nitta H, Kabuto M. Related Articles, Links
Evaluation of residential exposure to intermediate frequency magnetic fields.
Arch Environ Health. 2004 Dec;59(12):693-9.
PMID: 16789479 [PubMed - indexed for MEDLINE]
Posted by: ikhan700Posts: 15 :: 02-02-2007 :: | Reply to this Message
23: Shi Z, Neoh KG, Kang ET, Wang W. Related Articles, Links
Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles.
Biomaterials. 2006 Apr;27(11):2440-9. Epub 2005 Dec 9.
PMID: 16338001 [PubMed - indexed for MEDLINE]
26: Qu L, Luo PG, Taylor S, Lin Y, Huang W, Anyadike N, Tzeng TR, Stutzenberger F, Latour RA, Sun YP. Related Articles, Links
Visualizing adhesion-induced agglutination of Escherichia coli with mannosylated nanoparticles.
J Nanosci Nanotechnol. 2005 Feb;5(2):319-22.
PMID: 15853155 [PubMed - indexed for MEDLINE]
Zhang W, Yang H, Kong X, Mohapatra S, San Juan-Vergara H, Hellermann G, Behera S, Singam R, Lockey RF, Mohapatra SS. Related Articles, Links
Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene.
Nat Med. 2005 Jan;11(1):56-62. Epub 2004 Dec 26. Erratum in: Nat Med. 2005 Feb;11(2):233.
PMID: 15619625 [PubMed - indexed for MEDLINE]
33: Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, Bayston R, Brown PD, Winship PD, Reid HJ. Related Articles, Links
Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?
J Antimicrob Chemother. 2004 Dec;54(6):1019-24. Epub 2004 Nov 10.
PMID: 15537697 [PubMed - indexed for MEDLINE]
33: Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, Bayston R, Brown PD, Winship PD, Reid HJ. Related Articles, Links
Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?
J Antimicrob Chemother. 2004 Dec;54(6):1019-24. Epub 2004 Nov 10.
PMID: 15537697 [PubMed - indexed for MEDLINE]
I hope the above articles satisfy your curosity!
I.Khan MD
Posted by: ikhan700Posts: 15 :: 02-02-2007 :: | Reply to this Message
We have already cured, read that carefully cured not just treated, vasculitis including Takayasu diseases within two weeks.
A young girl was undiagnosed for one year untill she came to OUR clinic.
With the same treatment a girl who had lost her hearing was restored to nearly normal. She had even gone to the top centers in USA and was told she needed a experimental surgery.
Posted by: ikhan700Posts: 15 :: 02-02-2007 :: | Reply to this Message
Thank you for all these references. I am hopeful that there are some randomized clinical trials to support the treatment modalities that I asked above. Would it be possible for you to provide some references of randomized clinical trials?
Also I am curious what does ABNP in "Board Certified ABNP" mean?
Posted by: rqayyumPosts: 199 :: 02-02-2007 :: | Reply to this Message
ABNP
STANDS FOR AMERICAN BOARD OF NEUROLOGY & PSYCHIATRY
Posted by: ikhan700Posts: 15 :: 11-03-2007 :: | Reply to this Message
In fact, the reason I asked was that there is no such Board (ABNP) that is member of American Board of Medical Specialities (ABMS).
American Board of Psychiatry and Neurology (ABPN) is member of ABMS and as far as I know, it is not called American Board of Neurology and Psychiatry (ABNP).
Please correct me if I am wrong.
Posted by: rqayyumPosts: 199 :: 12-03-2007 :: | Reply to this Message
pls see this website
http://www.abpn.com/
Pls also see the history of ABNP as well. Its available on internet.
about abpn - our history
The American Board of Psychiatry and Neurology, Inc. (ABPN) is a nonprofit corporation that was founded in 1934 following conferences of committees appointed by the American Psychiatric Association, the American Neurological Association, and the then Section on Nervous and Mental Diseases of the American Medical Association. This action was taken as a method of identifying the qualified specialists in psychiatry and neurology.
The ABPN is one of 24 member boards of the American Board of Medical Specialties (ABMS).
Since 1935, when its first examination was delivered, the ABPN has been serving the public interest and promoting excellence in the practices of psychiatry and neurology through its certification and maintenance of certification processes. These processes are designed to identify qualified specialists through rigorous credential and training requirements, and successful completion of the Part I (computer-administered), and Part II (oral) board examinations for psychiatry, neurology, or neurology with special qualification in child neurology. ABPN committees are dedicated to developing tests that assess current scientific knowledge and clinical expertise required to achieve and maintain Board-certification.
Additionally, over the past several decades, the ABPN (sometimes in collaboration with other member boards) has sought from the ABMS, and gained approval for recognition of 11 subspecialties as listed below:
ABMS
Approval First
Examination Subspecialty
* 1959 Child and Adolescent Psychiatry
1989 1991 Geriatric Psychiatry
1990 1992 Clinical Neurophysiology
1991 1993 Addiction Psychiatry
1992 1994 Forensic Psychiatry
1998 2000 Pain Medicine
1999 2001 Neurodevelopmental Disabilities
2003 2005 Psychosomatic Medicine
2003 2005 Vascular Neurology
2005 anticipated 2008 Neuromuscular Medicine
2005 anticipated 2007 Sleep Medicine
*Certificates were issued prior to 1972 when ABMS recognition procedures were established.
As mandated by the ABMS, the ABPN continues making progress in the development of its Maintenance of Certification (MOC) program. MOC programs are designed to help assure the public that our Diplomates practice their specialties to the highest standards through four measurable components; professional standing, self-assessment and lifelong learning, cognitive expertise, and performance in practice.
ijaz
Posted by: ijazaliPosts: 151 :: 12-03-2007 :: | Reply to this Message
Dear Ijaz Sahib, please check my post above. I didn't ask about ABPN. In fact, I wrote that it is a member of ABMS. What I was asking was that whether ABNP (and not ABPN) was member of ABMS or not.
Posted by: rqayyumPosts: 199 :: 13-03-2007 :: | Reply to this Message
There is absolutely no level I evidence that nanotechnology is useful in "CURE" of cancer. The current investigational uses of this technology in the field of oncology are limited to diagnostic rather than therapeutic fileds.
The others i.e. auto immune disorders I don't know about.
[Edited by oncoman on 24-03-2007 at 12:26 PM GMT]
Posted by: oncomanPosts: 23 :: 20-03-2007 :: | Reply to this Message
Is it the same nanotechnology, researchers are using to aim specific target biomolecules. What is the target in case of HIV. Can you explain and refer to any website it will be very useful for all of us.
Posted by: yusmanPosts: 21 :: 27-03-2007 :: | Reply to this Message
HIV behaves like a autoimmune disease, along with immune suppression.
IgG IN IVIg has been used to stop HIV in its tracks.
Nanoparticles of silver have been used to get rid of HIV .
Some of this research is not avaliable to the general public.
To trat a disease one needs to know what is the cause! What is the your main target in HIV? Since HIV is a new Virus where did it come from?
You do your research and I will give you the rest of the answers.
I.Khan
Posted by: ikhan700Posts: 15 :: 25-04-2007 :: | Reply to this Message